Virulent mycobacteria cause arrest of phagosome maturation as a part of their survival strategy in hosts. This process is mediated through multiple virulence factors, whose molecular nature remains elusive. Using Mycobacterium marinum as a model, we performed a genome-wide screen to identify mutants whose ability to inhibit phagosome maturation was impaired, and we succeeded in isolating a comprehensive set of mutants that were not able to occupy an early endosome-like phagosomal compartment in mammalian macrophages. Categorizing and ordering the multiple mutations according to their gene families demonstrated that the genes modulating the cell envelope are the principal factors in arresting phagosome maturation. In particular, we identified a novel gene, pmiA, which is capable of influencing the constitution of the cell envelope lipids, thereby leading to the phagosome maturation block. The pmiA mutant was not able to resist phagosome maturation and was severely attenuated in mice. Complementing the mutant with the wild-type gene restored the attenuated virulence to wild-type levels in mice.
Mycobacterium tuberculosis, the causative agent of tuberculosis, claims the lives of over 1.7 million people per year. An estimated one-third of the world's population is infected with the tuberculosis bacillus (43) . The predilection of virulent mycobacteria to dwell in a hostile environment (macrophages) is considered central for effective pathogenesis. The mycobacteria persist inside macrophages by occupying an early endosome-like phagosomal compartment and avoiding the default pathway of phagosome maturation (PM) (3) . Phagosomes containing mycobacteria do not have pH values below pH 6.2 and are characterized by the absence of lysosome-associated membrane protein and lysosomal hydrolases, reduced levels of ATPase, and retention of the early endosomal markers Rab5 and TACO or mouse coronin (12, 30, 40) . Phagosomal factors that mediate the killing of mycobacteria at different stages have been described previously (2) .
Although several host cell mechanisms involved in the inhibition of PM have been proposed, an explanation for how mycobacteria establish a safe haven for themselves in the hostile environment in macrophages remains elusive. Possible roles for mycobacterial urease (17) and lipoarabinomannan in impeding phagosome acidification have been postulated (37) . Mycobacterial protein kinase G was shown to prevent transfer of mycobacteria to lysosomes (41) . Mycobacterial phosphoinositol mannosides that are similar to the mammalian phosphoinositol lipids enhance fusion of phagosomes containing mycobacteria with early endosomes (39) . In addition, Vergne and colleagues identified a secreted mycobacterial lipid phosphatase (SapM) that hydrolyzes phosphoinositol-3-phosphate, leading to inhibition of PM (38) . Pathogenic mycobacteria induce disruption of the actin filament network regulated by p38 mitogen-activated protein kinases, but the effector molecules have not been elucidated (2, 18) . The close apposition of the mycobacterial cell wall and the phagosomal membrane has been postulated to be the basis for PM inhibition by mycobacteria (10, 36) . In fact, cholesterol depletion with methyl-␤-cyclodextrin loosens the close apposition of the phagosomal membrane and the bacterium and results in fusion with lysosomes (9) . In summary, it has been concluded from these studies that more than one effector molecule is involved in the retardation of maturation of phagosomes containing mycobacteria (26) .
Mycobacterium marinum causes fatal infections in freshwater and saltwater fish, as well as amphibians. In humans it is the causative agent of a disease called swimming pool granuloma (7, 42) . However, a recent case study expanded the spectrum of infections caused by M. marinum to granulomatous pulmonary disease in humans (22) . Signature mechanisms of tuberculosis disease initiation, namely, retardation of PM and granuloma formation, appear to be evolutionarily conserved in both M. marinum and M. tuberculosis (4) . The faster growth of M. marinum than of M. tuberculosis and the phylogenetic closeness of these species are advantages for studies of mycobacterial pathogenicity. For example, granuloma-specific expression of virulence proteins belonging to the glycine-rich PE-polymorphic CG-repetitive sequences (PGRS) family and the mutant defect in strain MmW04 affecting intracellular survival and pigmentation have been identified using M. marinum as a model (13, 28) . Furthermore, studies with M. marinum mutants revealed that kasB is a novel drug target in mycobacteria. This gene is required for full elongation of mycolates. kasB mutants exhibit increased permeability of the cell wall and consequently impaired growth within macrophages (15) . The archetypal mycobacterial pathological feature, granuloma formation in tissues, has been examined in a study using M. marinum, in which it was shown that existing granulomas do not eliminate invading fresh mycobacteria that traffic to them (8) . In contrast, M. marinum has virulence factors that have not been found yet in other virulent mycobacteria, including escape from the phagosome to the cytosol and cell-to-cell spread by polymerization of the host cell actin (33) . The diversity of possible approaches used in these previous studies validates the utilization of M. marinum as a model to study mycobacterial pathogenesis.
We recently developed an efficient Tn5367 transposonbased mutagenesis system using phAE94 phage as a delivery vector in M. marinum (31) . In an attempt to identify genes involved in the inhibition of PM, here we used a modification of a mechanical screen previously described by Pethe and colleagues to select a library of M. marinum transposon mutants that were unable to stall PM (26) . The transposon-inactivated genes of the mutants with possible roles in restricting PM were identified by sequencing. The results revealed that mycobacterial cell wall-associated lipids and proteins have a predominant role in arresting PM. The role of cell wall components was further examined by characterization of a mutant having a transposon insertion in a hypothetical gene (pmiA) adjacent to putative hydroxylase and carboxylase genes. This mutant was unable to keep the phagosomes from maturing. Differences in colony morphology and the lipid profile suggest that this previously uncharacterized region is involved in lipid metabolism of the cell envelope, thereby inhibiting PM.
MATERIALS AND METHODS
Bacterial strains and cells. Transposon mutants of a fish isolate of M. marinum (ATCC 927) were generated (31) . M. marinum broth cultures and cultures on solid media were grown using Middlebrook 7H9 broth and 7H10 agar enriched with 10% oleic acid-albumin-dextrose complex at 30°C. The transposon mutants were cultured in these media containing 30 g/ml kanamycin at 30°C. Human peripheral monocytes were isolated from the buffy coat by Ficoll gradient centrifugation. Isolated monocytes were allowed to differentiate into macrophages in RPMI 1640 supplemented with 5% fetal bovine serum in human serumopsonized tissue-culture-grade petri plates with hydrophilic membranous bases (Lumox; Greiner Bio-One GmbH, Frickenhausen, Germany) for 7 days at 37°C in a 5% CO 2 atmosphere.
Screening for mutants not competent for retarding phagosome maturation. A bacterial inoculum was prepared from a pool of more than 4,000 individual mycobacterial transposon mutant colonies on Middlebrook 7H10 agar. A bacterial pellet was harvested by centrifugation and washed three times in phosphate-buffered saline (PBS). A small amount of glass beads (diameter, 0.2 mm) was added, and the suspension was shaken on a mill to disrupt the bacterial clumps. After sedimentation of the glass beads for 30 min, a fraction of the supernatant suspension was carefully removed and dispersed further by three passages through a 27-gauge needle.
Ten Lumox dishes with confluent human monocyte-derived macrophages (HMDMs) (3 ϫ 10 6 cells) were pulsed with 0.5 ml of colloidal iron dextran particles (Basic MicroBeads; catalog no. 130-048-001; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany) for 2 h, followed by a chase for 2 h. Then monolayers were washed with PBS to remove the excess beads. The macrophages were then pulsed with an M. marinum mutant library at a multiplicity of infection (MOI) of 10:1 for 2 h, rinsed with PBS to remove the excess bacteria, and chased overnight. The plates were then rinsed with RPMI once, equilibration buffer [50 mM piperazine-N,NЈ-bis(ethansulfonic acid) (PIPES) (pH 7.0), 50 mM KCl, 2 mM MgCl 2 , 5 mM EGTA, 1 mM dithiothreitol, 10 M cytochalasin B] was added, and the plates were incubated on ice for 20 min. Lysis buffer (50 mM PIPES [pH 7.0], 50 mM KCl, 2 mM MgCl 2 , 5 mM EGTA, 220 mM mannitol, 68 mM sucrose, 1 mM dithiothreitol, 10 M cytochalasin B) was added, and the cells were scraped off using a rubber policeman and collected in a tube. The macrophage lysate was passed 15 times through a 22-gauge needle for homogenization and then applied to a washing buffer-equilibrated Mini MACS column placed in a magnetic field. The flowthrough was collected for later analysis. The column was washed with wash buffer (2 mM EDTA and 0.5% bovine serum albumin in PBS), and the flowthrough was saved for analysis. The organelle fraction retained in the magnetic field in the column harboring the magnetic beads was eluted with elution buffer (10 mM triethanolamine, 10 mM acetic acid, 1 mM EDTA, and 0.25 M sucrose in PBS) after removal of the magnet. A small aliquot of the eluant was saved for analysis, while the remaining portion was centrifuged, resuspended in a small volume of Middlebrook 7H9 broth, and plated on 7H10 agar with kanamycin (30 g/ml). Agar dishes were incubated at 30°C for 5 days, and then the colonies were scraped from the plates. The harvested colonies were pooled, washed three times, and dispersed to obtain a single-cell suspension for infection of HMDMs. The selection procedure was repeated two more times. Aliquots of each preparation obtained were frozen at Ϫ80°C.
Western blot analysis of the lysosomal fraction recovered by magnetic separation. HMDMs were pulsed with Basic MicroBeads (Miltenyi Biotec) for 1 h, and this was followed by a chase for 2 h or overnight. Control macrophages were incubated without beads. After the chase, macrophages were lysed as described above, and magnetic separation of subcellular compartments was performed using the procedure described above for selection of mutants that were not competent for retarding phagosome maturation. Aliquots of the macrophage lysate, the fraction not binding to the magnetic column (flowthrough), and the eluted organelle fraction containing the magnetic beads were stored for analysis by sodium dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis (PAGE). Samples were solubilized in Laemmli sample buffer and separated by SDS-PAGE. Following electrophoretic transfer to a polyvinylidene difluoride membrane (GE Healthcare), the membrane was probed with early endosomal antigen 1 (EEA-1) antibody (BD Pharmingen, Heidelberg, Germany), lysosomeassociated membrane protein 1 (LAMP-1) antibody (BD Pharmingen), and glyceraldehyde-3-phosphate dehydrogenase protein (GAPDH) antibody (Zymed Laboratories, San Francisco, CA) and developed by enhanced chemiluminescence (ECL; GE Healthcare).
Southern blot analysis. Portions (4 g) of extracted chromosomal DNA of isolated M. marinum mutants and the wild type (WT) were digested with BamHI endonuclease. The restricted DNA was separated by electrophoresis and transferred to a nylon membrane. A probe specific for the aph gene was amplified from plasmid pUC4K (GE Healthcare) and labeled with digoxigenin using a DIG DNA labeling kit (Roche Applied Sciences, Mannheim, Germany). After prehybridization and hybridization the membrane was developed using the CDP Star luminescence detection reagent (Amersham Biosciences, Freiburg, Germany).
Identification of transposon insertion sites by sequencing. Genomic sequences flanking the transposon insertion sites were identified by using an arbitrary primed PCR and direct sequencing strategy as described previously (31) . Briefly, both sides flanking the transposon insertion site in a mutant were amplified in two separate nested PCRs. The primers used in the first round were primers ARB1 (5Ј-GGCCACGCGTCGACTAGTACNNNNNNNNNN-3Ј) and RPCRa1 (5Ј-CTTGCTCTTCCGCTTCTTCTC-3Ј) or primers ARB1 and RPCRb1 (5Ј-CAGGCACGTCGAGGTCTTTC-3Ј). Each first-round PCR product was used as a template and subjected to a second PCR. The primers used in the second round were primers ARB2 (5ЈGGCCACGCGTCGACTAGTAC-3Ј) and RPCRa2 (5Ј CTCTACACCGTCAAGTGCGAAGAG-3Ј) or primers ARB2 and RPCRb2 (5Ј-CTTTCAGATGGATGGCGTAG-3Ј). The product from the second round of PCR was purified using a QIAGEN PCR purification kit (QIAGEN, Hilden, Germany). DNA sequencing reactions were performed with primer RPCRa2 or RPCRb2 and Big Dye Terminator sequencing kits (Applied Biosystems, Foster City, CA). Reaction mixtures were analyzed with an ABI Prism 310 genetic analyzer. The sequences obtained were matched with the sequence of M. marinum ATCC BAA-535, and the homologies of the interrupted potential open reading frames (ORFs) with the "Omniome" protein database were analyzed using the BLASTX function available through the TIGR Comprehensive Microbial Resource at www.tigr.org.
Staining of mycobacteria with FITC or TRITC. WT or mutant M. marinum cells were suspended in 200 l of 0.1 M sodium bicarbonate buffer (pH 9.0) containing 1 mg/ml fluorescein isothiocyanate (FITC) or 0.1 mg/ml tetramethylrhodamine-5-isothiocyanate (TRITC) (both dyes were obtained from SigmaAldrich, Germany) and incubated at 30°C for 30 min. After incubation the excess dye was removed by three washes with PBS. The bacteria were then resuspended in RPMI for macrophage infection.
Phenotype screening of mutants by fluorescence microscopy. Mutants and the WT were screened for phagosome maturation by fluorescence microscopy. Briefly, adherent cultures containing 3 ϫ 10 6 HMDMs were transfected with 14 C-labeled bacteria were washed to remove unincorporated label and then dispersed to obtain single-cell suspensions prior to infection of HMDMs. The procedure described above for screening mutants that were not competent for retarding phagosome maturation was then employed to isolate phagosomes containing bacteria. The fractions of M. marinum WT, mutant P1, and heat-killed WT bacterial cells that were phagocytosed and delivered to phagolysosomes (PL) were quantified by measuring the radioactivities of the fractions with a ␤-scintillation counter.
Complementation of P1 mutant. A 3.8-kb region from M. marinum harboring the putative pmiA gene was PCR amplified using primers 5Ј-TGCGGCCGCTC TAGATGCGGTCAGGTATGTCAGCA-3Ј and 5Ј-GGGGGATCCACTAGTC TATCGACGCTGGCGCAT-3Ј and was cloned into plasmid pOLYG using a BD infusion kit (25) to obtain pGPC352 conferring resistance to hygromycin. Plasmid pGPC352 was transformed into mutant P1 by electroporation. P1(pGPC352) transformants were selected on 7H10 plates containing 30 g/ml kanamycin and 50 g/ml hygromycin. In addition, nested-deletion DNA fragments were generated from the 3,821-bp M. marinum fragment in pGPC352 using a combination of internal PCR primers. The amplified fragments were cloned in the same way into pOLYG to obtain pGPC369 to pGPC374 (see Fig.  6 ). These plasmids were transformed into the mutant for analysis of functional complementation. The P1 strains complemented with these plasmids were also labeled with 14 C and chased along with PL markers (microbeads) as described above.
Macrophage infection. Differentiated HMDMs were infected with M. marinum WT, P1, and P1(pGPC352) at an MOI of 10:1 and incubated at 37°C for 2 h. Cells were washed thoroughly with RPMI to remove extracellular bacteria and then incubated further at 37°C. At different times (2 h, 24 h, 48 h, 72 h, and 96 h) cells infected with all three bacterial strains were lysed using 0.1% SDS for 10 min, neutralized using 20% bovine serum albumin, and plated on 7H10 agar plates for enumeration of CFU. The CFU count obtained after 2 h was considered the CFU count for time zero postinfection.
Infection of mice. Specific-pathogen-free C57BL/6 mice were infected intravenously with 4 ϫ 10 5 viable M. marinum WT, mutant P1, and complemented P1(pGPC352) cells. At 1 and 2 weeks after infection, five mice from each group were sacrificed, and their livers and spleens were excised aseptically. Small equal samples of each liver and spleen were fixed in 4% formaldehyde for histopathological analysis. The remaining liver and spleen samples were homogenized, and diluted aliquots were plated on 7H10 agar. The plates were incubated for 5 days, and the CFU were counted.
Statistical analysis. A statistical analysis of fluorescence microscopy colocalization data was performed by using a one-way analysis of variance (ANOVA) post hoc range test and pairwise multiple comparisons with Tamhane's T2 corrections, assuming nonequal variances using the statistical software package SPSS 11.0.4 for Mac OS X (SPSS Inc., Chicago, IL). The CFU data for livers and spleens of mice infected with the M. marinum WT, P1, and P1(pGPC352) strains were analyzed for five mice each at weeks 1 and 2 with the same statistical software package. An analysis was done using one-way ANOVA for livers and spleens and each week separately, using Bonferroni corrections for liver week 1 CFU values and Tanhame's T2 corrections for liver week 2 and spleen week 1 and 2 CFU values.
Histological analysis. The spleen and liver of each mouse were placed in 4% neutral formalin and processed for paraffin embedding and subsequent sectioning. Consecutive sections (2 to 5 m) were mounted on glass slides, deparaffinated, stained with hematoxylin and eosin, and examined by a pathologist with no prior knowledge of sample identities.
Lipid extraction and analysis by TLC. Lipids of the M. marinum WT, mutant P1, and complemented P1(pGPC352) strains were isolated as described by Dobson et al. (11) . Briefly, the outer highly nonpolar lipids were isolated using petroleum ether. After removal of the outer lipid coat, the cells were treated with chloroform-methanol-0.3% aqueous NaCl to obtain the nonpolar lipid component. The defatted cells were subjected to alkaline methanolysis and digestion with tetramethylammonium hydroxide, followed by conversion of the salts obtained to methyl esters using iodomethane. The lipids and mycolic acid esters obtained were analyzed on Silica Gel 60 F 254 precoated high-performance thinlayer chromatography (TLC) plates (Merck, Darmstadt, Germany). Solvent systems were chosen as described by Dobson et al. (11) .
RESULTS
Screening for M. marinum mutants permitting phagosome maturation. To determine the mycobacterial genes that inhibit PM, a screen to isolate Tn5367 transposon mutants with defects in inhibition of PM was developed (Fig. 1) . The screen design took advantage of our finding that M. marinum can endure the hostile phagolysosomal milieu for a longer time (24 h) (data not shown). It was also based on the presumption that mutants that cannot inhibit PM are enriched in the phagolysosomal compartment. Based on this presumption, transposon mutants were chased together with magnetic microbeads into the phagocytic pathway of HMDMs. After an overnight chase the plasma membrane of the HMDMs was lysed under carefully controlled conditions, preserving the intracellular organelles. The homogenate containing the subcellular components was then passed through MACS columns under a magnetic field. Next, the column was removed from the magnetic field, and the mutants were eluted along with the PL marker. The beta-galactosidase activity, as a lysosomal marker (5) of the eluted and flowthrough fractions, was determined (data not shown), and the results revealed that phagolysosomes were strongly enriched in the fraction recovered. The lysosomal fraction was plated on 7H10 agar and incubated for 5 days, after which the bacterial colonies were just visible. These colonies were scraped off the agar, pooled, and carefully dispersed to obtain a single-cell suspension, which was used to infect a fresh culture of HMDMs. The selection procedure was repeated three times for further enrichment of mutants that were not capable of inhibiting PM. After the final selection 100 individual colonies were picked for further investigation. Magnetic isolation of lysosomal fraction. In order to validate the conclusion that the microbeads in our screening procedure were indeed localized in lysosomes, we performed a control experiment without bacteria (Fig. 2) . Macrophages without iron dextran microbeads, macrophages with microbeads after a 2-h chase, and macrophages with microbeads after an overnight chase were analyzed by SDS-PAGE and Western blotting to determine the presence of markers of the endosomal pathway, namely, LAMP-1 and EEA-1. The housekeeping gene product GAPDH was used as a control for equal loading of macrophage samples. For macrophages without microbeads we observed LAMP-1 and EEA1 staining in the lysate (Fig. 2, lane A) and flowthrough fractions (lane B), while only a minute amount was nonspecifically absorbed to the magnetic column (lane C). In contrast, for macrophages chased with iron dextran microbeads for 2 h or overnight there was significant isolation of LAMP-1-positive, EEA-1-negative, and GAPDH-negative lysosomal vesicles on the magnetic column (lanes F and I).
Defining transposon insertion sites by sequence and Southern blot analysis. In order to define transposon-disrupted regions and to identify independent insertions in identical genes or loci, 100 mutants selected for their inability to prevent PM were analyzed by sequencing the transposon inserted locus. Southern blot analysis was also performed to confirm that each mutant had only a single transposon insertion and to identify mutants with transposon insertions in the same gene (data not shown). The sequences obtained were compared with the available M. marinum ATCC BAA-535 sequence database of the Sanger Institute (http://www.sanger.ac.uk/cgi-bin/BLAST /submitblast/m_marinum) using BLAST. This analysis revealed that the insertions were not spread randomly across the genome. Instead, several regions with obvious accumulations of transposon insertions were identified (data not shown).
In general, our results describing the diversity of mycobacterial genes involved in retarding PM are in accordance with previous reports. Genes coding for FadD proteins and transporters and genes belonging to the PE/PPE gene family also appeared in our screen, as was the case in previous screens (26, 34) . Interestingly, a mutant having a transposon insertion in a gene involved in isoprenol biosynthesis that was identified by Pethe et al. was also identified by our screen. Moreover, we took utmost care to disperse bacterial clumps to obtain single bacilli in order to apply the selective pressure to each single mutant. This enabled us to identify genes coding for membrane proteins and secretory proteins. Stewart et al. speculated that underrepresentation of such proteins in genetic screens has been due to cross presentation (34). Our screen also identified genes contributing to the resistance of mycobacteria to killing by macrophages, as reported independently by other workers (14, 19, 20, 23, 29, 32) . Surprisingly, transposon insertion sites of 15 mutants could not be mapped to the available M. marinum ATCC BAA-535 genome database, although similar genes in other mycobacterial genomes were identified, albeit with low probability scores. This indicated either that there is phylogenetic distance between M. marinum ATCC 927, a fish isolate, and ATCC BAA-535, a human isolate, or that unidentified mycobacterial prophages were present.
Immunofluorescence microscopy of HMDMs infected with mutants. We employed Rab5-and Rab7-GFP fusion protein and LAMP-1 antibody staining to characterize the phagosomes containing M. marinum WT or 6 mutants chosen randomly from the 100 mutants isolated after the three rounds of selection. Fluorescence micrographs revealed that phagosomes containing the WT indeed retained Rab5 (Fig. 3A) even after an overnight chase, whereas LAMP-1 (Fig. 3C) and Rab7 (Fig.  3E) were excluded. In contrast, phagosomes containing mutants were observed to colocalize with Rab7 and LAMP-1. Quantifying the colocalization events in more than 100 individual phagosomes for each mutant with each marker showed that one of the six randomly selected mutants (P1) exhibited the strongest reduction in the capacity to resist PM; for this mutant 73% Ϯ 3% of the phagosomes acquired LAMP-1 and 69% Ϯ 4% acquired Rab7. In contrast, for WT bacteria only 22% Ϯ 2% of the phagosomes acquired LAMP-1 and 13% Ϯ 2% acquired Rab7 (Fig. 4 A) . The differences between the WT FIG. 2 . Western blot analysis of lysosomal fraction recovered by magnetic separation. HMDMs were pulsed with Basic MicroBeads (Miltenyi Biotec) for 1 h, followed by a chase for 2 h (lanes D to F) or overnight (lanes G to I). Lanes A to C contained control macrophages without beads. After the chase, macrophages were lysed (lanes A, D, and G), and magnetic separation of subcellular compartments was performed by using the same procedure that was used for selection of M. marinum mutants that were incompetent for retarding phagosome maturation. Lanes B, E, and H contained a macrophage lysate fraction that did not bind to the magnetic column (flowthrough). 
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and complemented mutant P1(pGPC352) versus mutant P1 are statistically significant (Fig. 4B) . The colocalization analysis indicated that the gene inactivated by transposon insertion in the P1 mutant indeed has an important function in preventing PM. Mutant P1 is attenuated in HMDMs. Our results show that WT M. marinum was able to multiply at 37°C until day 3 in HMDMs, as shown in Fig. 5 , although the growth rate was low. For mutant P1 there was a steady decline in survival. These findings correlated with recent findings of Kent et al. (21) .
After 72 h a rapid increase in multiplication of the WT was observed. In contrast, the survival of mutant P1 in HMDMs was severely attenuated, as shown by the rapid decrease in survival with a lag phase of 24 h. In contrast, the mutant complemented strain P1(pGPC352) was virulent and had a growth pattern identical to that of the WT.
Transcomplementation of P1 and coelution of 14 C-labeled bacterial cells with lysosomal marker. The transposon insertion site of mutant P1 was mapped to a sequence that was very similar (97% sequence identity) to ORF MM3386 in the M. marinum ATCC BAA-535 genome. Neither the gene encoding the putative 203-amino-acid peptide sequence of M. marinum ATCC 927 nor MM3386 encoding a putative 197-amino-acid peptide was found to have significant similarity to genes in any other genome in the current databases (NCBI, EBI, and TIGR Comprehensive Microbial Resource). No signature patterns, domains, repeats, motifs, or features in the putative peptide sequence could be predicted with confidence using the latest SMART (Simple Modular Architecture Research Tool) at EMBL, the latest BLAST engines at the NCBI, or the latest releases of the PROSITE search engine at http://www.expasy .ch/tools/scanprosite/, except for an RGD motif at amino acid positions 113 to 115 of the putative peptide sequence. The gene was given the provisional name phagosome maturation inhibition A (pmiA).
Even though the database queries could not suggest any function for the interrupted pmiA gene, the downstream genes on the complementary strand were identified as putative hydrolase (MM3387) and carboxylase (MM3388) genes. A sketch of the organization of these genes is shown in Fig. 6 . The region spanning the transposon insertion site was cloned into a pOLYG shuttle vector, electroporated into P1, and selected on plates containing hygromycin and kanamycin. To examine whether reconstitution of the disrupted gene restored the WT phenotype, HMDMs were infected with [
14 C]palmitate-labeled bacteria [WT, heat-killed WT, P1, and P1(pGPC352)] and then pulsed and chased with marker for PL and selected on a MACS column under a magnetic field, as described above for the transposon mutant screen. Bacteria that coeluted with the PL marker were quantified with a ␤-scintillation counter. As shown in Fig. 7 , the heat-killed M. marinum coeluted with the PL marker, whereas a minor fraction of the WT coeluted with PL. A significant fraction of P1 coeluted with the PL marker, whereas the level for the transcomplemented P1(pGPC352) strain was the same as the WT level. We inferred from these observations that the P1 mutant was not competent enough to resist PM and, when reconstituted with the appropriate gene, was able to regain the lost phenotype. To narrow the range of genes affected by the transposon insertion and responsible for the phenotypic change in P1, a set of nested deletions in the complementation plasmid was generated. The range of WT chromosomal sequences covered by the nested plasmids is shown in Fig. 6 . Plasmid pGPC374 harboring just 1,332 bp of the WT sequence spanning pmiA and no other putative mycobacterial ORF was sufficient to restore the WT phenotype, as less than 5% of P1 bacterial cells harboring this plasmid coeluted with the PL marker (Fig. 7) . These results confirmed that the transposoninterrupted pmiA gene itself was responsible for the inhibition of PM and eliminated the possibility of involvement of any polar effects on the neighboring genes.
In vivo survival of P1 in mice. C57BL/6 mice were intravenously challenged with WT, P1, and P1(pGPC352). One and two weeks postinfection mice were sacrificed, and the numbers of bacteria in spleens and livers were determined. Box plots of liver and spleen CFU are shown in Fig. 8A and B . Analysis of the number of CFU recovered from infected mice by one-way ANOVA for livers and spleens and for each week separately showed that the capacity to maintain viable bacterial cells in the infected organs was significantly diminished for the mutant P1 compared to both WT and P1(pGPC352); the P values were Ͻ0.004 for livers for the first and second weeks, Ͻ0.001 for spleens for the first week, and Ͻ0.011 for spleens for the second week.
Histopathology of infected organs. Infection with M. marinum mutant P1 resulted in significantly reduced pathological changes in C57BL/6 mouse livers. The capacity of P1 to induce granuloma formation was clearly attenuated, as the number and extent of epitheloid granulomas were reduced with this mutant compared to the results obtained with both the WT and complemented mutant P1(pGPC352), especially in the second week. However, in P1(pGPC352)-infected animals the number of granulomas was more variable than the number in WT-infected animals. The majority of the granulomas in P1-infected animals developed in the lobules, and fewer granulomas developed in the portal tracts. Granulomas in P1-infected animals also showed more and stronger signs of inflammation around the granulomas (i.e., mainly lymphocytes and a few granulocytes). A striking feature of the liver sections of WTand P1(pGPC352)-infected animals was the severe endothelialitis, whereas the endothelialitis in P1-infected animals was only marginal (Fig. 9 ; data for the first week not shown). One of the five WT-infected livers was entirely necrotic, with widespread hepatocyte damage. Necrosis in the granulomas was observed in none of the animals in the other groups. The pathological changes in the spleens were less pronounced. In on October 1, 2017 by guest http://iai.asm.org/ the second week the red and white pulp of the spleens of two of five WT-infected animals had very few granulomas and there were no granulomas in two of five animals, and in one animal the entire spleen was necrotic. In the complemented mutant P1(pGPC352)-infected animals all five spleens had a few small granulomas in the white pulp. In contrast, the histology of the P1-infected animals was normal, and there were granulomas in only one animal. Noncording phenotype and lipid profile. Unexpectedly, P1 produced flat, smooth, transparent colonies when it was recovered from the organs of mice. The WT bacteria retained the rough colony morphology, and the morphology of the complemented P1(pGPC352) strain reverted back almost completely to the WT morphology (Fig. 10) , confirming that the altered colony morphology of P1 was due to disruption of the pmiA gene. A comparison of the mycolic acid profiles of the WT, P1, and P1(pGPC352) strains revealed no obvious differences, as determined by TLC. Therefore, we used a systematic approach to study the lipid profiles, as described by Dobson et al. (11) . When the highly hydrophobic outer layers of lipids were extracted using petroleum ether and analyzed by TLC, a lipid moiety in the WT was resolved which was missing in the P1 mutant and was present in the complemented P1(pGPC352) mutant (Fig. 11) .
DISCUSSION
Virulent mycobacteria hijack macrophages, interfere with the intracellular signaling, and reside within a specialized phagocytic compartment. In order to understand the genes contributing to the inhibition of PM, we used a screen to select for transposon-containing M. marinum mutants localizing in the PL. Although many genetic approaches have been used to elucidate the mechanisms of mycobacterial pathogenesis, studies using mutant strains are considered to be more effective than studies using other strategies (24) . Investigation using transposon mutant pools has been successfully used by different groups to examine genetic requirements for mycobacterial virulence in vivo in mice and survival in macrophages and to identify genes involved in arresting PM and acidification of phagosomes. Our screen revealed genes orchestrating the cell envelope and thereby playing a key role in facilitating the inhibition of PM.
The validity of a screen can be assessed only by demonstrating that at least some of the mutants have the predicted phenotype (26) . We looked for colocalization of phagosomal markers Rab5 and Rab7 and LAMP-1 with phagosomes containing mutants as arrest of PM has been shown to occur between stages controlled by Rab5 and Rab7 (40) . Using immunofluorescence microscopy, we identified the P1 mutant, of which approximately 70% of the phagosomes acquired markers of late endosomes and were not found to retain the early endosomal marker Rab5. Coelution of radiolabeled bacteria with the PL marker showed that there was enrichment of P1 in PL compared to WT and P1(pGPC352), indicating that there was PM. As expected for mutants defective in preventing PM, P1 has diminished survival in macrophages and is severely attenuated in vivo in mice. Histopathological analysis of the P1-infected organs revealed reduced pathological changes with fewer granulomas in the liver and spleen, a macrophage-mediated reaction. Together, these results strongly suggest that the pmiA gene takes part in modulating PM.
A striking finding was that P1 produced flat, smooth, transparent colonies when it was recovered from the organs of mice. Lipid biosynthesis and fatty acid-modifying genes have been found to be upregulated to a level of activity that is twice the normal level in an intracellular milieu. From these observations it has been inferred that M. tuberculosis undergoes immense changes in cell envelope composition upon infection and that this microbe is capable of mobilizing mechanisms to evade host immune responses by modifying lipid and cell wall components (27) . Our observations substantiate this hypothesis. Altered colony morphology of the P1 mutant was due to a defect in cording, as observed microscopically. A correlation between virulence and cording has long been appreciated. Virulent mycobacteria form braided serpentine cords, as noted by Koch. The cord-forming capacity is attributed to multiple cell envelope lipids. M. tuberculosis cording requires cycloproponation of mycolic acids, and in M. marinum disruption of kasB leads to noncording colonies (15, 16) . Although mycolic acid synthesis was not affected in our P1 mutant, systematic lipid profiling was used to identify a lipid of the outer cellular envelope in the WT that was missing in the P1 mutant. When complemented, the mutant regained the lipid moiety. These results suggest a function for the pmiA gene in lipid metabolism or transport, which would also be consistent with the functions of the neighboring putative hydrolase (MM3387) and carboxylase (MM3388) genes. The orthologs of the latter genes in M. tuberculosis are presumed to be involved in fatty acid metabolism (6) . The mycobacterial cell envelope is composed of a variety of complex lipids. Very little information on the genetics of these lipids and their physiological role is available. Our results revealed that an as-yet-uncharacterized gene adjacent to putative hydrolase and carboxylase genes is involved in lipid metabolism. We concluded that the lipid moiety missing in the P1 mutant participates in impeding PM, as previous reports have shown that mycobacterial lipids can modify membranes (35) and also prevent actin nucleation, which is necessary for PM (1) .
Using an efficient screening technique, we identified genes possibly involved in the inhibition of PM. Furthermore, by investigating the phenotypes of the mutants using both in vitro and in vivo techniques, we identified a previously unknown gene, pmiA, which has a role in modulating lipids of M. marinum, thereby stalling PM. These findings not only indicate the role of pmiA but also underscore the important role of mycobacterial membrane lipids in modulating PM. The identification of previously unknown genes has been a common feature in recent screens used to examine mycobacterial virulence genes (27) . Identification and characterization of the pmiA gene, a virulence gene in the myriad of mycobacterial genes with unknown functions, should be an immense help in understanding the pathogenesis of mycobacteria. Our future work to characterize the pmiA gene and the genes controlling the mycobacterial cell wall-associated lipids and proteins preventing PM might yield valuable targets for drug research and development.
